Status:
COMPLETED
A Prospective Active-Reference Study of Gaboxadol in Primary Insomnia
Lead Sponsor:
H. Lundbeck A/S
Conditions:
Primary Insomnia
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
To evaluate the efficacy safety and tolerability of gaboxadol in primary insomnia
Detailed Description
To compare the hypnotic efficacy and safety of different dose levels of gaboxadol with placebo in non-elderly patients with primary insomnia over two weeks of treatment
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- diagnosis of Primary insomnia
Exclusion
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
End Date :
June 1 2004
Estimated Enrollment :
675 Patients enrolled
Trial Details
Trial ID
NCT00209937
Start Date
January 1 2003
End Date
June 1 2004
Last Update
March 30 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.